Search results for "Control"

showing 10 items of 13168 documents

Glycated serum proteins and glucose tolerance

1988

Glycated serum proteins (GSP), stable glycated hemoglobin (HbA1c) together with some metabolic parameters were evaluated in 120 subjects, 30 with normal glucose tolerance (NGT), 30 with impaired glucose tolerance (IGT), 30 with non-insulin-dependent diabetes mellitus (NIDD), and 30 with insulin-dependent diabetes mellitus (IDD). GSP levels were significantly higher in IGT, NIDD and IDD than in NGT. HbA1c levels were not significantly higher in IGT in comparison with NGT, but were significantly higher in NIDD and in IDD than in NGT and IGT. GSP correlated better than HbA1c with all metabolic parameters considered. Taking into account the distribution of the values, GSP showed a smaller overl…

AdultBlood GlucoseMalemedicine.medical_specialtyGlycosylationendocrine system diseasesEndocrinology Diabetes and MetabolismImpaired glucose toleranceHba1c levelchemistry.chemical_compoundEndocrinologystomatognathic systemReference ValuesInternal medicineDiabetes mellitusInternal MedicinemedicineHumansTriglyceridesGlycated HemoglobinGlucose tolerance testmedicine.diagnostic_testbusiness.industryCholesterolnutritional and metabolic diseasesBlood ProteinsGeneral MedicineGlucose Tolerance TestMiddle Agedmedicine.diseaseBlood proteinsCholesterolDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 2chemistryHyperglycemiaMetabolic control analysisFemaleGlycated hemoglobinbusinesshormones hormone substitutes and hormone antagonistsActa Diabetologica Latina
researchProduct

Association between irisin and homocysteine in euglycemic and diabetic subjects

2014

Abstract Objectives The aim of study was to explore whether a relationship exists between homocysteine and irisin in type 2 diabetes (T2D) patients—a population with a high risk of developing cardiovascular disease—and euglycemic controls. Design and methods 69 T2D patients and 75 control subjects (adjusted by body mass index (BMI)) were included in the study. Irisin and homocysteine concentrations and anthropometric and biochemical variables were determined. Results Levels of homocysteine were significantly higher (11.0 ± 3.0 vs 12.4 ± 4.2 μmol/l) and levels of irisin were lower (279 ± 58 vs 263 ± 38 ng/ml) in T2D patients. When both T2D and controls were considered, irisin was found to co…

AdultBlood GlucoseMalemedicine.medical_specialtyHomocysteineClinical BiochemistryPopulationType 2 diabetesBody Mass Indexchemistry.chemical_compoundInternal medicineMyokineHumansInsulinMedicineClinical significanceeducationHomocysteineAgedCardiovascular risk factors Homocysteine Irisin Myokine NicotinamideAnalysis of Varianceeducation.field_of_studybusiness.industryFastingGeneral MedicineMiddle AgedAnthropometryControl subjectsmedicine.diseaseLipidsFibronectinsEndocrinologyDiabetes Mellitus Type 2chemistryFemalebusinessBody mass indexClinical Biochemistry
researchProduct

Type 2 diabetes and impaired glucose tolerance are associated with word memory source monitoring recollection deficits but not simple recognition fam…

2013

It has been established that type 2 diabetes, and to some extent, impaired glucose tolerance (IGT), are associated with general neuropsychological impairments in episodic memory. However, the effect of abnormalities in glucose metabolism on specific retrieval processes such as source monitoring has not been investigated. The primary aim was to investigate the impact of type 2 diabetes and IGT on simple word recognition (familiarity) and complex source monitoring (recollection). A secondary aim was to examine the effect of acute breakfast glycaemic load manipulations on episodic memory.Data are presented from two separate studies; (i) 24 adults with type 2 diabetes and 12 controls aged 45-75…

AdultBlood GlucoseMalemedicine.medical_specialtyMemory EpisodicExperimental and Cognitive PsychologyType 2 diabetesAudiologyDevelopmental psychologyImpaired glucose toleranceBehavioral NeuroscienceDietary SucroseGlucose IntolerancemedicineHumansEpisodic memoryDepression (differential diagnoses)AgedBreakfastMemory DisordersRecallNeuropsychologyWaterRecognition PsychologyGlucose Tolerance TestMiddle Agedmedicine.diseaseCrossover studyGlucoseDiabetes Mellitus Type 2Case-Control StudiesWord recognitionMental RecallFemalePsychologyPhysiologybehavior
researchProduct

Chronic Hyperinsulinemia Does Not Increase the Production Rate of High-Density Lipoprotein Apolipoprotein AI

2013

Objective— In vitro studies showed that insulin stimulates the production of apolipoprotein AI (apoAI). Thus, we hypothesized that chronic hyperinsulinemia could contribute to the increase in the production of high-density lipoprotein apoAI that is observed in metabolic syndrome. Approach and Results— We performed an in vivo kinetic study with stable isotope in 7 patients with insulinoma who showed hyperinsulinemia but no insulin resistance, 8 patients with insulin resistance, and 16 controls. Insulinemia was 3.1× ( P <0.01) higher in patients with insulinoma or insulin resistance than in controls in the fasting state and, respectively, 3.5× and 2.6× ( P <0.05) higher in the fed stat…

AdultBlood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentBiologyYoung Adultchemistry.chemical_compoundInsulin resistanceHigh-density lipoproteinHyperinsulinismInternal medicinemedicineHyperinsulinemiaHumansInsulinInsulinomaMetabolic SyndromeApolipoprotein A-IInsulinMiddle AgedPostprandial Periodmedicine.diseasePancreatic NeoplasmsKineticsEndocrinologychemistryCase-Control StudiesChronic DiseaseMultivariate AnalysisFemaleInsulinomaInsulin ResistanceMetabolic syndromeLipoproteins HDLCardiology and Cardiovascular MedicineHyperinsulinismLipoproteinArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

Physical activity does not inevitably improve quality of life in young adults with type 1 diabetes

2016

Relationships between exercise, glucose control and diabetes dependent quality of life (DDQoL) are not straightforward. We investigated the DDQoL of 99 persons with type 1 diabetes and linked it to individual amount of weekly physical activity and HbA1c. Physically active lifestyle was not associated with better DDQoL or glucose control.

AdultBlood GlucoseMaleyoung adultsmedicine.medical_specialtyquality of life questionnaireGlucose controlEndocrinology Diabetes and MetabolismPhysical activityphysical activity030209 endocrinology & metabolism03 medical and health sciencesYoung Adult0302 clinical medicineEndocrinologyQuality of life (healthcare)Diabetes mellitusSurveys and QuestionnairesInternal MedicinemedicineHumans030212 general & internal medicineYoung adultta315Life StyleRetrospective StudiesGlycated HemoglobinType 1 diabetesexercisebusiness.industryta3141General Medicinemedicine.diseaseDiabetes Mellitus Type 1Physical therapyQuality of LifeFemalebusinessDiabetes Research and Clinical Practice
researchProduct

Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus

1990

A clinical trial was undertaken to determine whether intensive thymopentin administration enhances remission of insulin-dependent diabetes (IDDM) during the first year after diagnosis. Dosage with insulin was minimized with target control of blood glucose levels less than or equal to 7.8 mmol/l before meals. Remission was defined as a prolonged period after IDDM onset (not less than 3 months) characterized by a non-insulin-receiving (NIR) state in which target metabolic control was reached without administration of insulin and with a valid C-peptide response, evaluated after standard breakfast. Sixteen IDDM patients aged 12-31 years, recruited within 2 weeks of initiation of insulin therapy…

AdultBlood Glucosemedicine.medical_specialtyAdolescentmedicine.medical_treatmentImmunologyGastroenterologyInternal medicineDiabetes mellitusmedicineHumansInsulinImmunology and AllergyThymopentinChildGlycemicImmunity CellularC-Peptidebusiness.industryInsulinRemission InductionHemoglobin AReceptors Interleukin-2medicine.diseaseClinical trialTiterDiabetes Mellitus Type 1EndocrinologyChild PreschoolInsulin dependent diabetesMetabolic control analysisThymopentinbusinessmedicine.drugJournal of Autoimmunity
researchProduct

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

2008

BACKGROUND: Insulin glargine is a once-daily basal insulin analog with prolonged duration of action and absence of an evident peak. Glargine is associated with reduced frequency of hypoglycemic episodes (mostly nocturnal) as well as effective glycemic control. Maintenance of good metabolic control before conception and throughout pregnancy is essential to lower the risk of fetal malformations. Glargine might be a valuable alternative in the management of pregnancies complicated by diabetes mellitus. However, because its clinical utility has not been established, the use of glargine is not currently recommended during pregnancy. OBJECTIVE: The aim of this study was to retrospectively evaluat…

AdultBlood Glucosemedicine.medical_specialtyInsulin IsophanePregnancy in DiabeticsInsulin GlargineSettore MED/13 - EndocrinologiaInsulin aspartPregnancyDiabetes mellitusInternal medicinemedicineOutpatient clinicInsulin lisproHumansHypoglycemic AgentsInsulinPharmacology (medical)Body Weights and MeasuresFemurInsulin AspartGlycemicRetrospective StudiesPharmacologyGlycated HemoglobinType 1 diabetesPregnancyInsulin LisproInsulin glarginebusiness.industryglargine type 1 diabetesPregnancy Outcomemedicine.diseaseInsulin Long-ActingEndocrinologyDiabetes Mellitus Type 1Case-Control StudiesFemalebusinessmedicine.drugClinical therapeutics
researchProduct

Endothelial dysfunction in PCOS. role of obesity and adipose hormones

2006

PURPOSE: Polycystic ovary syndrome (PCOS) is an extremely prevalent disorder in which elevated blood markers of cardiovascular risk and altered endothelial function have been found. This study was designed to determine if abnormal carotid intima-media thickness (IMT) and brachial flow-mediated dilation (FMD) in young women with PCOS may be explained by insulin resistance and elevated adipocytokines. METHODS: A prospective study in 50 young women with PCOS (age: 25.2 +/- 1 years; body mass index [BMI]: 28.7 +/- 0.8) and 50 matched ovulatory controls (age: 25.1 +/- 0.7 years; BMI: 28.5 +/- 0.5) was performed. Carotid IMT, brachial FMD, and blood for fasting glucose, insulin, leptin, adiponect…

AdultBlood Glucosemedicine.medical_specialtyinsulinBrachial ArteryendotheliumPeptide Hormonesmedicine.medical_treatmentAdipokineleptinBody Mass IndexInsulin resistanceInternal medicineAdipocytesmedicineBody Fat DistributionHumansResistinObesityProspective Studiescardiovascular diseasesEndothelial dysfunctionAdiponectinadiponectinbusiness.industryInsulinLeptinpcosEndothelial dysfunction in PCOS: role of obesity and adipose hormones.nutritional and metabolic diseasesGeneral Medicinemedicine.diseasePolycystic ovaryVasodilationCarotid ArteriesEndocrinologyCase-Control Studiespcos; endothelium; insulin; adiponectin; leptincardiovascular systemCytokinesFemaleResistinEndothelium VascularInsulin ResistanceTunica IntimaTunica MediabusinessBlood Flow VelocityPolycystic Ovary Syndrome
researchProduct

Hormone therapy is associated with better body composition and adipokine/glucose profiles

2012

Objective: The aim of this study was to evaluate the possibility of preventing the metabolic health consequences of postmenopausal hypogonadism with the use of long-term hormone therapy (HT). Methods: We used a monozygotic co-twin control design including 10 twin pairs (aged 56-62 y) discordant for HT (duration of HT, 2-10 y). In addition, 14 premenopausal women (aged 29-35 y) who did not use HT were studied to evaluate the differences in metabolic health between the premenopausal and postmenopausal states. Body composition was determined, and waist-to-hip ratio was used as an estimate for fat distribution. Serum sex steroids, sex hormone-binding globulin, and serum lipid and glucose profil…

AdultBlood Glucosenaisetmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentkehon koostumusCo twin controlAdipose tissueAdipokineCarbohydrate metabolismAdipokinesSex Hormone-Binding GlobulinInternal medicineLeukocytesmedicineHumansRNA MessengerGonadal Steroid HormonesMuscle SkeletalChemokine CCL2kehonkoostumusMetabolic healthkaksostutkimusWaist-Hip Ratiobusiness.industryEstrogen Replacement TherapyadipokoinesObstetrics and Gynecologyta3141Twin studyTwins MonozygoticMiddle Agedadipokiinitmedicine.diseaseLipidsPostmenopauseMenopauseEndocrinologyAdipose TissuePremenopauseEstrogenCase-Control StudiesBody CompositionFemaleHormone therapyInsulin ResistancebusinessMenopause
researchProduct

The Use of Frozen-Thawed Platelet-Derived Phospholipids as a Confirmatory Test for the Diagnosis of Lupus Anticoagulants. Comparison with Two Commerc…

1999

Lupus anticoagulants (LAs) belong to acquired circulating anticoagulants interfering with phospholipid-dependent coagulation tests. Owing to the remarkable variability among patients, SSC guidelines recommend more than one test to detect and confirm the presence of LAs. However, this is an expensive procedure and greatly raises the work load of the laboratory. A standardised platelet-derived phospholipid preparation was obtained and platelet neutralisation (PNP) procedures with APTT and DRVVT reagents were performed on plasmas from 16 patients with LAs and from 41 control subjects. In comparisons, STAclot-PNP and DVVconfirm clotting assays were conducted. PNP by using APTT or DRVVT reagents…

AdultBlood PlateletsMaleinorganic chemicalsAdolescentmedicine.drug_classCoefficient of variationCoagulation testingHumansMedicineheterocyclic compoundsPlateletPhospholipidsAgedBlood coagulation testCryopreservationLupus anticoagulantChromatographySystemic lupus erythematosusbusiness.industryAnticoagulantHematologyMiddle Agedmedicine.diseaseControl subjectsenzymes and coenzymes (carbohydrates)Freeze DryingLupus Coagulation InhibitorImmunologyFemaleBlood Coagulation TestsbusinessThrombosis Research
researchProduct